Improving long-term outcomes in idiopathic membranous nephropathy using a distinctive cyclosporine regimen
{{output}}
Background: Patients with severe or progressive idiopathic membranous nephropathy (IMN) should receive immunosuppressive therapy (IST). Alkylating agents, corticosteroids and cyclosporine A (CsA) may be associated with substantia... ...
